About Us

Elsevier Business Intelligence Publications

Elsevier Business Intelligence is the leading source for biopharma and medical device regulatory, reimbursement and business intelligence. With the largest, most experienced team of analysts in the industry, EBI is connected to a comprehensive network of decision makers in industry and government – including U.S. FDA, EMEA and China’s SFDA – who provide critical intelligence you won’t find elsewhere. Find out why regulators and top life sciences executives in the U.S., Europe and Asia trust EBI publications like “The Pink Sheet”, IN VIVO and PharmAsia News to deliver what you need to know, and why you need to know it – subscribe today.

Where biomedical industry professionals turn for news, insight and analysis

Elsevier Business Intelligence places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Built on the proud heritage of F-D-C Reports, Windhover Information and Medtech Insight, Elsevier Business Intelligence is a leader in the field of healthcare industry information.

Trust the largest team of journalists dedicated exclusively to your industry

Our highly experienced and respected editorial teams report on the latest regulatory, legislative, and business news affecting the drug, biotechnology, medical device, non-prescription drug, nutritionals, and cosmetics industries.

Our publications:

  • “The Pink Sheet” – Expert, in-depth analysis of biopharma regulatory, legislative, legal and business developments.
    Click here for a free trial of “The Pink Sheet”  for comprehensive biopharmaceutical regulatory, legal and business analysis.
  • “The Pink Sheet” DAILY – Daily, in-depth analysis of the key developments shaping the biopharma industry.
    Sign-up for a free trial to “The Pink Sheet” DAILY today.
  • “The Gold Sheet” – Insightful analysis to help you comply with U.S. and international pharmaceutical manufacturing QA/QC requirements.
    Request a free trial of “The Gold Sheet” Today!
  • “Pharmaceutical Approvals Monthly” – In-depth coverage of U.S. drug approvals, including FDA approval actions by classification.
    Receive insight into the drug & biologic approval process to help guide your strategic decision making. Click here for a free trial for Pharmaceutical Approvals Monthly.
  • PharmAsia News  Highly specialized industry insight on the Asian marketplace, plus around-the-clock news feeds from Asia.
    Click here to start your 30-day, risk-free trial of PharmAsia News – Immediate business intelligence from China, India, Japan and the Pacific Rim, from the publishers of “The Pink Sheet.”
  • IN VIVO The premier strategic business resource for the biopharma, medtech, and diagnostics industries.
    Find out how IN VIVO‘s monthly premier strategic business resource for biopharma, med-tech, and diagnostic industries can help you make your business decisions. Click here for a free sample issue.
  • Start-Up In-depth profiles of leading-edge companies and technology, including the most important new trends in business and technology.
    Find out how Start-Up‘s monthly leading intel on emerging medical ventures can help you make critical business decisions. Click here for a free sample issue.
  • The RPM Report Actionable insight on regulation, policy, FDA and CMS to apply directly to your decision-making.
    Don’t miss another article from The RPM Report, Subscribe today — follow this link for details.

Find out why The New “Pink Sheet” is the world’s most widely-read resource for expert, in-depth analysis of biopharma regulatory, legislative, legal and business developments.